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Abstract
Background: The non-tuberculous mycobacteria include those mycobacterium species that are not members of
the Mycobacterium tuberculosis complex, the causative agent of pulmonary tuberculosis and Mycobacterium leprae.
In Zambia, Non-tuberculous Mycobacteria are gaining recognition as pathogens of public health significance. However,
there is scanty information on the isolation and speciation of these organisms for better patient management,
consequently reducing the burden of these infections. Given the above information, the thrust of this study was
to isolate and characterize NTM from humans and water in Namwala district of Zambia.
Method: This was a cross-sectional study were 153 individuals with suspected TB were sampled from four health
facilities in Namwala district, sputum samples were also collected. Additionally, 149 water samples were collected
from different water drinking sources such as Tap water, Borehole water, rivers, wells and streams. Standard TB
culture methods were employed to isolate Non-tuberculous Mycobacteria and later 16S–23S internal transcribed
spacer region Sequencing was employed to characterize NTM.
Results: Seven (7, 4.6%) NTM species were identified from humans with M. arupense (3, 42.9%) being the most
common organism, while twenty three (23, 15.4%) NTM were identified from water with the common species
being Mycobacterium gordonae (5, 21.7%). Mycobacterium avium and Mycobacterium fortuitum were both identified
from human and water samples.
Conclusion: This study has shown the isolation of NTM species from humans and water. The isolation of NTM from
drinking water sources could signify a public health risk to humans.
Keywords: Namwala, NTM, Water, Mycobacteria, Zambia
Background
The Non-tuberculous Mycobacteria (NTM) include those
mycobacterium species that are not members of the Myco-
bacterium tuberculosis complex (MTC), the causative
agent of pulmonary tuberculosis (TB) and Mycobacterium
laprae [2, 3, 24]. They are normal inhabitants of natural
waters, drinking waters, animals, birds and soils [25, 33, 41].
The environment is the primary source of infection of these
mycobacteria to humans. NTM have also been recovered
from meat, fish, dairy products, fruits, vegetables and
specially unpasteurized milk suggesting a public health
risk for these bacteria [19].
Human-to-human transmission of NTM is generally
uncommon, although there is evidence of transmission of
certain NTM species such as Mycobacterium kansasii [33].
Although members of the MTC are largely known to
cause the majority of the mycobacterial infections world-
wide, infections due to NTM are also emerging [17].
There are 172 different species of NTM but the most
potentially pathogenic of these are Mycobacterium avium,
Mycobacterium intracellulare, Mycobacterium kansasii,
Mycobacterium xenopi, and Mycobacterium abscessus
[17]. These organisms are capable of causing pulmonary
disease, disseminated disease and localized lesions, mostly
in immune-compromised individuals. Pulmonary diseases
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are the most frequently encountered and have been reported
to account for up to 94% of cases of NTM associated disease
[28]. People living with Human Immunodeficiency Virus
(HIV) and Acquired Immunodeficiency Syndrome (HIV/
AIDS), represent one of the most vulnerable populations to
NTM infections, as well as a higher risk for complications
and poor disease outcomes. Those receiving immunosup-
pressive therapy secondary to organ transplantation, cancer,
autoimmune disease and those with diabetes mellitus may
also be more susceptible to NTM infections compared to
the general population [2].
Non-tuberculous Mycobacteria can display clinical and
radiological features similar to those exhibited by MTC,
hence the need for species identification. Distinguishing
between MTC and NTM infections may be challenging,
especially in low income countries such as Zambia
where Acid Fast Bacilli (AFB) smear microscopy is
mainly used for MTC diagnosis. Even though AFB smear
microscopy, allows for rapid diagnosis of mycobacteria,
it does not differentiate MTC from NTM. This may lead
to NTM related infections being under-diagnosed or
misdiagnosed as TB [7].
In Zambia, NTM have also been recognized as patho-
gens of major public health significance with the advent
of HIV and AIDS [5, 6, 21]. However, only scanty studies
have demonstrated the isolation and characterization of
mycobacteria species in humans and water. This study
therefore, aimed at isolation and characterization of




The study was conducted in Namwala district of
Zambia. Namwala is a rural district situated in the
southern province of Zambia and is one of the districts
with a large number of pastoral farmers. It has the highest
TB prevalence in both animals and humans [22, 23]. It
covers an estimated total area of about 10,000 km2 and
lies between latitudes 15 and 17°S of the equator and
longitude 25 and 27° E. (Fig. 1). The greater area of its
traditional land is covered by the Kafue flood plains of the
Kafue River. These offer nutritive varieties of rich lush
green grass for both cattle and wildlife for a greater part of
the year than the surrounding Savannah woodlands [24].
It supports approximately 30,000 herds of cattle and
44,000 Kafue lechwe [22]. Agriculture is the main
economic activity, and majority of the people keep
livestock. Humans and animals commonly share the same
micro-environments such as water drinking points,
especially in dry seasons [30], increasing the possibility
of interspecies disease transmission or contamination of
water sources, which could potentially lead to a zoonotic
transmission to humans [18].
Study design
This was a cross-sectional study in adolescent and adult
presumptive TB patients. In addition, water samples
were collected. For human sampling, sputum samples
were collected from patients seeking medical attention
at four local health centers in Namwala district, namely,
Namwala district Hospital, Chitongo Health Centre,
Kabulamwanda Health Centre and Maala Rural Health
Centre. Patients who presented with TB-like symptoms
such as chronic (Defined as ≥ 2 weeks) productive
cough, loss of appetite, fever, fatigue, headache and
night sweats were enrolled in the study. Participants
who presented with other ailment were not included in
our study.
Water samples were collected from common water
drinking points in areas where the study participants
came from. The water collection points comprised of
taps, communal boreholes, open wells, and streams/
river. Community health workers in these areas helped in
accessing these water points. Our sampling was purposive
as study subjects were selected based on the above
mentioned characteristics.
Study period




After routine microscopy with the Ziehl–Neelsen (ZN)
staining technique, the samples were stored in cetylpyridi-
nium chloride (CPC) transport medium (Sigma-Aldrich,
Steinheim, Germany, a mixture of 1.0% CPC and 2.0%NaCl)
and kept at ambient temperature at the health facilities until
they were taken to Tropical Diseases Research Centre
(TDRC), TB Reference Laboratory (Ndola) for processing.
At TDRC TB Reference Laboratory, samples were deconta-
minated using the Petroff method [29] and cultured on
Lowenstein-Jensen (LJ) medium. The cultures were incu-
bated at 37 °C and examined for growth weekly for at least
8 weeks and results recorded. Microscopic examination of
positive cultures using ZN staining method was performed
to detect the presence of AFB.
Water samples
One hundred and forty nine (149) water samples were
collected from various drinking points such as streams,
boreholes, tap and rivers in Namwala Central, Maala,
Kabulamwanda and Chitongo. An amount of 150 ml
water was collected in sterile whirlpak plastic bags and
immediately placed in a cool box containing ice packs
and transported to the laboratory where they were
stored in CPC media (BD Diagnostics, Sparks, MD) until
processed.
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Hundred and Fifty (150 ml) of water was filtered
through 0.45 μm nitrocellulose membrane filters (Millipore
Corporation, Bedford, MS, USA) by vacuum filtration using
a Manifold Filtration System (Sartorius AG, Goettingen,
Germany). The membranes were transferred into sterile
screw-capped specimen containers with 10 ml of 0.005%
CPC. The surface of the membranes was abraded vigor-
ously and thoroughly with a sterile plastic inoculating loop.
The samples were then exposed to 0.005% CPC for 30 min
at room temperature. The mixture was then centrifuged at
3000×g for 20 min. The pellet was washed twice with 1 ml
sterile normal saline and finally re-suspended in 1 ml sterile
distilled water. The suspension (0.5 ml) was inoculated
on LJ slants and incubated at 37 °C. The cultures were
examined for growth for up to 8 weeks and results
recorded. Microscopic examination of positive cultures
was done using Ziehl Neelsen staining method to detect
the presence of AFB.
Sequencing of 16S- 23S rRNA ITS region
Upon detection of AFB in positive cultures, the Mycobac-
terial growth was identified as either MTC or NTM using a
rapid identification test known as Capilia TB-Neo Kit
(TAUNS Laboratories, Inc. Japan), following manufacturer’s
instructions (capilia.co.jp/english/capilia_tb-neo.html). To
obtain genomic DNA for sequencing, the invitrogen
TRIzol™ Reagent was used for DNA extraction accord-
ing to Hongbao et al. [15]. Thereafter, polymerase chain
reactions (PCRs) were performed followed by sequencing
of the 16S – 23SrRNA Internal Transcribed Spacer region
with primers Sp1 (5′-ACC TCC TTT CTA AGG AGC
ACC-3′) and Sp2 (5′-GAT GCT CGC AAC CAC TAT
CCA-3′) [34]. Sequencing was performed using an ABI
sequencer (Applied Biosystem Inc.) at the school of
Veterinary Medicine, University of Zambia. The obtained
sequences were aligned using MEGA version 7and the
alignments were then blasted against the NBCI database
with Mycobacterium taxid 85,007 as the reference organ-
ism. The strain name with the highest E.value and identity
hit and score was chosen.
Results
Isolation of NTM in sputum and water samples
Based on morphological characteristics on LJ media and
acid fastness by the ZN method, 17 (11.11%) mycobacter-
ial species were detected out of the 153 study participants.
Seven (7) (4.6%) were identified as NTM while 10 (6.5%)
were MTC. However, co-infection of NTM and MTC was
not observed among the suspected TB patients.
Fig. 1 Map of Namwala district
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Thirty two 32 (21.5%) NTM were isolated from 149
water samples collected. The majority of NTM were
isolated from borehole water sources 17(53.1%) followed
by river 9 (28.1%), stream 3 (9.4%), dam 2 (6.3%), and tap
1 (3.1%) water sources.
Molecular characterization of NTM in humans and water
All the seven (7) NTM isolated were characterized to
species level, with the most isolated species being
Mycobacterium arupense 3 species (42.9%) (Table 1).
Out of 32 NTM isolated from water samples, 23 NTM
species were characterized with the most common being
Mycobacterium gordonae, 5 species (21.7%); Mycobacterium
senegalense, 3 species (13.0%); Mycobacterium peregrinum,
3 species (13.0%), Mycobacterium fortuitum, 3 species
(13.0%) and Mycobacterium gilvum, 2 species (8.7%)
(Table 1). Nine (9) NTM were uncharacterized. Myco-
bacterium avium and Mycobacterium fortuitum were
both isolated in humans and water samples. Of the four
study sites in Namwala district, Maala had the most
NTM species identified (11 species) while Chitongo
had the least NTM species (2 species).
Discussion
Non-tuberculous Mycobacteria have gained much clinical
significance in the last couple of decades in both immuno-
compromised and immune-competent individuals [1].
Water is a documented source of NTM infection in
humans, but it is not the only source [38]. Currently,
very little data exists on the NTM species distribution
in humans and water in Africa, Zambia inclusive. It was
against this background that this present study was for-
mulated and to the best of our knowledge, this might
be the first study in Zambia to isolate and characterize
NTM from humans and water simultaneously.
In the present study, a range of NTM from humans
and water in Namwala district, an agro-pastoral district
located in Southern province of Zambia were isolated.
The study found the overall prevalence of NTM in
humans in Namwala district to be 4.6%, among patients
presenting with TB-like symptoms at local health centers.
This is comparable to a study done in Shanghai China,
were the overall prevalence of NTM in humans was
5.9% [44].
In the current study, out of 149 water samples
collected from various study sites in Namwala district,
32 (21.5%) samples were positive for NTM using
phenotypic identification method, indicating that NTM
were common in water sources of Namwala district.
Our study also found a high isolation rate of NTM in
borehole water sources followed by river, dam, stream
and lowest in tap water sources. The most prevalent
NTM species isolated was Mycobacterium gordonae.
Although another study carried out in Sri Lanka [10]
showed a high frequency of isolation of mycobacteria
from aquarium water and surface water (rivers, streams)
with the most common NTM being Mycobacterium
fortuitum), These findings in our study could be due to
high levels of organic matter and soil in borehole waters
and surface waters (rivers, dams, streams) contributing
to the mycobacterial flora. The piping systems used in
boreholes may support the formation of biofilms which
favors the growth and multiplication of NTM [37]. Some
pipe materials have been shown to contribute to biofilm
formation particularly iron pipes [37] The capacity of
mycobacteria to form biofilms has been demonstrated in
studies done elsewhere [9, 13]. In Germany, 90% of bio-
film samples from pipes of various water distribution
systems contained Mycobacteria, signifying that Myco-
bacteria biofilms are present in piping systems [35].
The low mycobacterial load in tap water sources
observed in our study could probably be related to the
lethal effect of chlorine to mycobacteria, since tap
water is usually chlorinated in Namwala district by the
local water supply company.
The isolation rate of NTM in both water and human
samples was also highest in Maala area as compared to
the other study sites in Namwala district of Zambia.
This can be attributed to the fact that Maala is
surrounded by open grasslands with a lot of Dambos,
rivers and papyrus flora, with reeds that enhance the
Table 1 NTM species isolated in Humans and Water in
Namwala district
NTM species n Frequency (%)
Humans (N = 153, n = 7)
M. arupense 3 42.9
M. abscesus 1 14.3
M. avium 1 14.3
M. fortuitum 1 14.3
M. nebraskense 1 14.3
Water (N = 149, n = 23)
M. gordonae 5 21.7
M. senegalense 3 13.0
M, fortuitum 3 13.0
M. peregrinum 3 13.0
M. kumamotonense 1 4.3
M. simiae 1 4.3
M. avium 1 4.3
M. gilvum 2 8.7
M. flavescens 1 4.3
M. housetonense 1 4.3
M. smegmatis 1 4.3
M. parafinicum 1 4.3
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formation of microfilms and subsequently increase the
multiplication of NTM [13].
A range of pathogenic NTM species were also isolated
in the present study and the most common organism
was Mycobacterium arupense. This is the first study in
Zambia to report the isolation of Mycobacterium
arupense in human sputum samples. Cloud et al., [8]
identified Mycobacterium arupense for the first time in
human clinical samples in the United States of America.
Other studies done in Japan [26], Taiwan [40]; and in
Greece [27] also reported the isolation of Mycobacterium
arupense in human sputum samples. In all these four
studies Mycobacterium arupense was of clinical signifi-
cance. Mycobacterium arupense is a novel mycobacterium
species potentially pathogenic and has been associated
with causing human pulmonary infections [36]. Therefore,
Mycobacterium arupense isolated from humans in this
study could possibly be of clinical significance as the
patients presented with symptoms of pulmonary infection.
Other NTM species that were isolated in humans
were Mycobacterium abscessus, Mycobacterium avium,
Mycobacterium fortuitum and Mycobacterium nebras-
kense. All these species have been found to cause disease in
immune compromised and immune competent individuals.
Mycobacterium abscessus has been reported to be the
leading cause of lower respiratory tract infections among
the rapidly growing NTM species [6, 16]. Mycobacterium
avium has also been known to cause opportunistic infec-
tions in humans and animals [11] while Mycobacterium
nebraskense is an NTM pathogen that has been associated
with nodular pulmonary disease [32].
Drinking water has been suggested as a reservoir for
many pathogenic and potentially pathogenic NTM
such as Mycobacterium avium complex, Mycobacterium
gordonae, Mycobacterium kansasii, Mycobacterium fortui-
tum, Mycobacterium simiae, Mycobacterium senegalense,
Mycobacterium chelonae and Mycobacterium xenopi [12,
31, 38]. In our study, a number of pathogenic and poten-
tially pathogenic NTM species were isolated from water
samples of Namwala district. The most prevalent
NTM species was Mycobacterium gordonae, followed
by Mycobacterium fortuitum, Mycobacterium senegalense,
and Mycobacterium peregrinum. This is in partial agree-
ment with the findings of the study conducted by Thomson
and others in Brisbane, Australia, where Mycobacterium
gordonae was the most commonly isolated species in
natural and municipality water sources [38]. Mycobac-
terium gordonae is one of the least pathogenic of the
mycobacterium species isolated. It is usually a contam-
inant or colonizer in immune competent individuals;
however, it has been found to be pathogenic in HIV
infected patients who are severely immune compromised
[4]. Apart from AIDS, underlying immunue suppression,
advanced structural lung disease such as emphysema,
pneumoconiosis, alcoholism, chronic lung disease, diabetes
mellitus and malignancy have all been reported as risk
factors for invasive infections [4, 43]. Therefore, Mycobac-
terium gordonae isolated from clinical samples should not
be automatically considered as a contaminant or colonizer
especially in immune compromised patients or patients
with the above mentioned risk factors.
Mycobacterium fortuitum, Mycobacterium senegalense
and Mycobacterium peregrinum all belong to the Myco-
bacterium fortuitum complex. A study done by Velayati
et al. [42] also found Mycobacterium fortuitum to be the
most common species in water. Immune compromised
individuals are more likely to be infected with Mycobac-
terium fortuitum from water sources. Infections caused
by this organism include skin and soft tissue infections,
lymphadenitis, pulmonary infections and catheter related
infections [11].
Mycobacterium senegalense and Mycobacterium pere-
grinum have also been isolated in water elsewhere [20, 37].
They are potentially pathogenic NTM species and have
been implicated to cause disease both in immune compe-
tent and immune compromised persons [39]. The isolation
of Mycobacterium senegalense in water sources of
Namwala district is another key finding in our study.
Mycobacterium senegalense is a rapidly growing myco-
bacterium species that has been reported to cause bovine
farcy among cattle in east Africa and bovine farcy has
been known to cause huge economic loss [14]. Therefore,
isolation of this NTM species in water in the present
study poses a risk to cattle in Namwala district because
this is a pastoral area [21]. Further, all Mycobacterium
senegalense species isolated in this study were from Maala
and this area has the largest number of cattle.
Conclusion
This study has shown the isolation of NTM species from
humans and water with Mycobacterium arupense and
Mycobacterium gordonae being the most prevalent.
However, there is no evidence of human to human
acquisition but rather a common environmental source,
water. Further, the wide presence of NTM in the water
sources of Namwala could pose a risk especially for the
immune compromised individuals. Therefore, preven-
tion of public health risk of NTM should take into
account water treatment before it’s accessed for domes-
tic consumption.
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